---
created: 2025-04-13
updated: 2025-04-13T10:51
id: Ez3WdE1-om
specialty: neuro
specialty_id: 181
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::
  - theme/firstaid::13-psychiatry::03-pharm::07-buspirone
  - source/ak-step1-v11::
  - theme/firstaid::13-psychiatry::03-pharm::13-atypical-antidepressants
  - source/ak-step1-v11::
  - source/ome-banner::clinical::12-psychiatry
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::13-psychiatric::18-buspirone
  - source/ak-step1-v11::
  - theme/pixorize::03-pharm::16-psych::buspirone
  - source/ak-step1-v11::
  - theme/sketchypharm::06-neuro/psych::03-antidepressants-&-anxiolytics::04-bupropion,-mirtazapine,-trazodone
  - source/ak-step1-v11::
  - theme/uworld::100-999::200-299::247
  - source/ak-step1-v11::
  - theme/uworld::100-999::200-299::248
  - source/ak-step1-v11::^other::^highyield::1-highyield
  - source/ak-step1-v11::^systems::neuro::pharmacology
  - source/ak-step2-v11::!shelf::fm::no-dupes
  - source/ak-step2-v11::!shelf::psych::no-dupes
  - source/ak-step2-v11::
  - theme/amboss::psych
  - source/ak-step2-v11::
  - theme/nbme
  - source/ak-step2-v11::
  - theme/ome::12-psychiatry::01-anxiety
  - source/ak-step2-v11::
  - theme/resources-by-rotation::fm::ome::psych::pharm
  - source/ak-step2-v11::
  - theme/resources-by-rotation::psych::fapsych::pharm
  - source/ak-step2-v11::original-decks::dorian::fam::ome::psych::pharm
  - source/ak-step2-v11::original-decks::dorian::psych::fapsych::pharm"
type: flashcard
---

# Question
Buspirone is primarily used to treat **generalized anxiety** disorder (2nd line)

---

# Answer
nonBZD anxiolytic, slow onset of action, lacks mm relaxant & anticonvulsant properties, no risk of dependence